Markets
UK Prime Minister Meets With President Trump In Washington
Look! Over there! At Nvidia! Don’t look at me. (Andrew Harnik/Getty Images)
BLAME GAME

Nvidia or Trump’s tariffs? Who’s to blame for the S&P 500’s tumble into the red for 2025?

Let’s look at the market scoreboard.

Luke Kawa

After the close on Wednesday, Nvidia released a set of quarterly results that, while impressive on the surface, failed to wow traders.

Ahead of the market open on Thursday, President Donald Trump recommitted to 25% tariffs on imports from Canada and Mexico, as well as a 10% levy on Chinese imports effective March 4.

Which bears more blame for the S&P 500’s 1.6% drop, which erased its gains for the year?

Well, let’s turn to the market scoreboard.

A basket of stocks selected by Goldman Sachs as being particularly vulnerable to potential Trump tariffs fell 2% on the day. That’s bad! The Nasdaq 100, however, was worse, with a 2.8% decline.

If we go back to the start of last September (an arbitrary line for beginning to price in potential impacts of a Trump presidency), this day ranks in the 77th percentile for how this cohort performed compared to the Magnificent 7. That is to say, in only about 23% of sessions did tariff-exposed stocks outperform the tech giants by more than they did on Thursday. For tariff-vulnerable stocks versus the Nasdaq 100, this was a 75th percentile day over the same time frame.

Tariff-sensitive stocks suffered a larger decline last Friday than they did on Thursday, whereas this was far and away the Nasdaq 100’s worst session since the DeepSeek-induced plunge.

Zooming out, since September, Goldman’s basket of tariff-exposed stocks is up modestly, while a basket of stocks judged to be well insulated from trade barriers is down nearly 5%.

(The same performance gap holds true if we’re just looking since Election Day, too!)

There is not strong evidence to suggest that tariffs have been a big driver of price action in general, and on Thursday in particular.

If the stock market is in the process of “waking up” to the threat of tariffs, Thursday was more akin to groggily hitting the snooze button. Again.

Don’t overthink it: when a ̶$̶3̶ $2.93 trillion chip designer tumbles after reporting earnings and the rest of the sector goes with it, Occam’s Razor applies.

An appropriate diagnosis of what’s happening in the here and now — particularly during a market drawdown — is important because it offers a lens into what can or might happen next, and what kind of catalysts investors should look out for that might change the character of the tape.

If the phrase “growth scare” is coming up more and more often but the pain points in the market are the meltdowns in former high-flying stocks that aren’t considered to be highly economically sensitive and credit spreads are still relatively well behaved, then it isn’t a growth scare yet! But it could certainly become one. Or not!

Of note: financials, an indisputably cyclical sector whose outlook is inextricably tied to the health of the US economy, was the best-performing S&P 500 sector ETF on Thursday, putting in a 0.6% gain.

If you’re in the midst of a growth scare or tariff-induced sell-off, the top things to monitor are the evolution of the economic data and any chatter related to trade barriers. If you’re looking for what reverses a momentum breakdown, the answer is much more likely to be found in technicals and flows — key levels where certain important names might find a floor. To that end, Nvidia has broken down below its 200-day moving average, and Tesla is trading nearly bang on that level.

More Markets

See all Markets
markets

Cisco beats expectations for Q2 sales and EPS; Q3 margin forecast is light

Cisco beat Wall Street expectations for sales and earnings in its fiscal second-quarter results, which it released after the close of trading Wednesday.

Shares slid 7% in the after-hours session. A lighter-than-expected forecast for fiscal third-quarter profit margins may have played a role.

For the fiscal second quarter of 2026, the computer networking equipment giant reported:

  • Non-GAAP earnings per share of $1.04 vs. the $1.02 expected by Wall Street analysts, according to FactSet.

  • Sales of $15.35 billion vs. the $15.11 billion consensus expectation.

  • AI infrastructure orders from hyperscalers of $2.1 billion vs. $1.3 billion in the previous quarter.

  • Revenue guidance for fiscal Q3 of between $15.4 billion and $15.6 billion vs. $15.19 billion consensus estimate. 

  • Adjusted gross margin guidance for fiscal Q3 of 65.5% to 66.5%, compared with analysts’ forecasts for 68.2%.

  • Fiscal year 2026 sales guidance of $61.2 billion to $61.7 billion vs. previous guidance of between $60.2 billion and $61.0 billion.

Along with other companies like Lumentum, Corning, and new S&P 500 member Ciena, which provide things like the wiring and networking equipment needed to connect server racks, Cisco shares have had a strong start to 2026 as the AI data center boom continues to roll. 

Through the end of trading on Wednesday they were up 11% for the year, compared to a 1.4% gain for the S&P 500.

This is a developing story.

markets

McDonald’s Q4 earnings, sales beat Wall Street estimates

McDonald’s reported Q4 results on Wednesday that beat Wall Street’s expectations, which the company attributes to its value leadership.

For the last three months of 2025, the fast-food giant reported:

  • Adjusted earnings per share of $3.12, compared to the $3.05 analysts polled by FactSet were expecting.

  • Revenue of $7 billion, higher than the $6.8 billion analysts were penciling in.

  • Global comparable-store sales growth of 5.7%, compared to the 3.9% growth analysts were expecting. In the US, comparable sales grew 6.8% versus the 5.4% that was expected. The company said this was driven by positive check and guest count growth primarily from successful marketing promotions.

McDonalds has emphasized discounts and promotions, such as its $5 meal deals. “McDonalds value leadership is working,” CEO Chris Kempczinski said in a statement.

Shares were little changed in after-hours trading.

markets

Gilead rises after earnings beat driven by HIV drug sales

Gilead rose more than 5% on Wednesday after it reported quarterly earnings and revenue that beat Wall Street estimates, driven by sales of its HIV drugs.

For the last three months of 2025, Gilead reported:

  • Adjusted earnings per share of $1.86, compared to the $1.81 the Street was expecting.

  • $7.9 billion in revenue, more than the $7.6 billion the Street was penciling in. Late last year the company began selling Yeztugo, a twice-yearly HIV prevention shot. CEO Daniel O’Day told analysts it “has already exceeded our coverage goals and is rapidly gaining market share.”

For the full year in 2026, the company expects:

  • Adjusted earnings per share of $8.45 to $8.85, compared to the $8.79 analysts forecast.

  • Revenue of $29.6 billion to $30 billion, compared to the $29.92 billion the Street was expecting. The company anticipates Yeztugo will contribute $800 million in revenue in 2026.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.